Status:
UNKNOWN
Personalised Diet, Exercise and Emotional Support for Lung Cancer Patients Having Chemotherapy, Radiotherapy or Immunotherapy Treatment
Lead Sponsor:
Imperial College Healthcare NHS Trust
Conditions:
Lung Cancer
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Background The term 'prehabilitation' refers to a period of time before treatment and often includes diet, exercise and/or wellbeing plans to help patients through their cancer treatment. Prehabilita...
Detailed Description
Background Prehabilitation programmes are increasingly used before surgery to optimise outcomes. However, 55% of patients are treated non-surgically with oncological treatment. Prehabilitation has po...
Eligibility Criteria
Inclusion
- Adults (aged ≥ 18 years) diagnosed with lung cancer
- Able to give informed consent
- Due to embark on a chemotherapy, radiotherapy and/or immunotherapy treatment pathway
Exclusion
- On a surgical pathway
- Have had previous lung cancer surgery
- Unable to understand verbal or written English
- Unable to give informed consent
Key Trial Info
Start Date :
October 28 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05318807
Start Date
October 28 2022
End Date
September 1 2023
Last Update
May 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imperial College Healthcare NHS Trust
London, United Kingdom, W6 8RF